Jeff Hrkach
Impact in
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
-
- Nanoplatforms for cancer theranostics
- Bone Tissue Engineering Materials
- 3D Printing in Biomedical Research
Papers in
-
- Nanoparticle-Based Drug Delivery 3
- Electrospun Nanofibers in Biomedical Applications 1
-
- Protein Degradation and Inhibitors 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Róbert Langer (2 shared papers)William C. Zamboni (1 shared paper)Nicholas J. Panaro (1 shared paper)Anil K. Patri (1 shared paper)Vladimir P. Torchilin (1 shared paper)Piotr Grodzinski (1 shared paper)André E. Nel (1 shared paper)Robert J. Lee (1 shared paper)
- Journals
- Cancer Research (4 papers)Drug Delivery and Translational Research (1 paper)Clinical Cancer Research (1 paper)The Annals of Thoracic Surgery (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomSingapore
In The Last Decade
Jeff Hrkach
7 papers receiving 443 citations
Peers
Comparison fields: 5 of 69
- Biomaterials 311
- Biomedical Engineering 182
- Pharmaceutical Science 20
- Surgery 126
- Process Chemistry and Technology 8
Countries citing papers authored by Jeff Hrkach
This map shows the geographic impact of Jeff Hrkach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Hrkach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Hrkach more than expected).
Fields of papers citing papers by Jeff Hrkach
This network shows the impact of papers produced by Jeff Hrkach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Hrkach. The network helps show where Jeff Hrkach may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Hrkach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 209 | |
| 2 | 2012 | 197 | |
| 3 | 2020 | 35 | |
| 4 | 2013 | 5 | |
| 5 | 2012 | 4 | |
| 6 | 2014 | 2 | |
| 7 | 2014 | 2 | |
| 8 | 2015 | 0 |
About Jeff Hrkach
Jeff Hrkach is a scholar working on Biomaterials, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 8 papers that have together received 454 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Electrospun Nanofibers in Biomedical Applications (1 paper), Graphene and Nanomaterials Applications (1 paper), Protein Degradation and Inhibitors (1 paper), Microtubule and mitosis dynamics (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Biomaterials (311 citations), Biomedical Engineering (182 citations), Pharmaceutical Science (20 citations), Surgery (126 citations) and Process Chemistry and Technology (8 citations). Jeff Hrkach has collaborated with scholars based in United States, United Kingdom and Singapore. Frequent co-authors include Róbert Langer, William C. Zamboni, Nicholas J. Panaro, Anil K. Patri, Vladimir P. Torchilin, Piotr Grodzinski, André E. Nel, Robert J. Lee, George A. Taylor and Joseph P. Vacanti. Their work appears in journals such as Cancer Research, Drug Delivery and Translational Research, Clinical Cancer Research, The Annals of Thoracic Surgery and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.